1.Berrettini S, Carabelli A, Sellari‐Franceschini S, Bruschini L, Quartieri F, Sconosciuto F, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy. 1999;54(3):242-8.
2.Rondón C, Campo P, Togias A, Fokkens WJ, Durham SR, Powe DG, et al. Local allergic rhinitis: Concept, pathophysiology, and management. Journal of allergy and clinical immunology. 2012;129(6):1460-7.
3.Mims JW. Epidemiology of allergic rhinitis. International Forum of Allergy & Rhinology. 2014;4(S2):S18-S20.
4.Torres-Borrego J, Molina-Teran A, Montes-Mendoza C. Prevalence and associated factors of allergic rhinitis and atopic dermatitis in children. Allergologia et immunopathologia. 2008;36(2):90-100.
5.Bellanti JA, Wallerstedt DB, editors. Allergic rhinitis update: epidemiology and natural history. Allergy and Asthma Proceedings; 2000: OceanSide Publications, Inc.
6.Bousquet J, Annesi‐Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clinical & Experimental Allergy. 2005;35(6):728-32.
7.Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. Journal of allergy and clinical immunology. 2001;108(1):S2-S8.
8.Bielory L, Chun Y, Bielory B, Canonica G. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta‐analysis. Allergy. 2011;66(5):686-93.
9.Spector SL. Overview of comorbid associations of allergic rhinitis. Journal of allergy and clinical immunology. 1997;99(2):S773-S80.
10.Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. International immunopharmacology. 2011;11(11):1646-62.
11.Colás C, Galera H, Anibarro B, Soler R, Navarro A, Jáuregui I, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clinical & Experimental Allergy. 2012;42(7):1080-7.
12.Lack G. Pediatric allergic rhinitis and comorbid disorders. Journal of Allergy and Clinical Immunology. 2001;108(1, Supplement):S9-S15.
13.Camelo-Nunes IC, Solé D. Allergic rhinitis: indicators of quality of life. Jornal Brasileiro de Pneumologia. 2010;36(1):124-33.
14.Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Current medical research and opinion. 2004;20(3):305-17.
15.Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6(3):373-8.
16.Blaiss MS, editor. Allergic rhinitis: Direct and indirect costs. Allergy and Asthma Proceedings; 2010: OceanSide Publications, Inc.
17.Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Current medical research and opinion. 2006;22(6):1203-10.
18.Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. The Laryngoscope. 2011;121(9):1830-3.
19.Sharif M. Zadolmosaferin. 1st ed. Jalaleddin; Qom, Iran: 2008.
20.Jurjani SI. Zakhireh-i Kharazmshahi, Photo Offset from the Original Hand Written Manuscript. Edited by Saeedi Sirjani. Tehran: Iran Cultural Publications; 1976. [In Persian].
21.Exire-Azam ACM. Tehran. Iran: Nasle Nikan. 2008.
22.Scadding G, Durham S, Mirakian R, Jones N, Leech S, Farooque S, et al. BSACI guidelines for the management of allergic and non‐allergic rhinitis. Clinical & Experimental Allergy. 2008;38(1):19-42.
23.Shah-Arzani M. Tib-e-Akbari. Ghom: Jalal-ed-Din. 2008.